Bora Pharmaceuticals Co., LTD.

TWSE:6472 Voorraadrapport

Marktkapitalisatie: NT$75.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Bora Pharmaceuticals Dividend

Dividend criteriumcontroles 1/6

Bora Pharmaceuticals is een dividendbetalend bedrijf met een huidig rendement van 1.61% dat ruimschoots wordt gedekt door de winst.

Belangrijke informatie

1.6%

Dividendrendement

38%

Uitbetalingsratio

Gemiddelde opbrengst industrie2.2%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeelNT$12.000
Winst per aandeelNT$31.12
Dividendrendementsvoorspelling0%

Recente dividendupdates

Recent updates

Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?

Oct 04
Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?

Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Jul 18
Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: 6472 betaalt al minder dan 10 jaar dividend en gedurende deze periode zijn de betalingen volatiel geweest.

Groeiend dividend: De dividendbetalingen van 6472 zijn gestegen, maar het bedrijf heeft pas 9 jaar dividend uitgekeerd.


Dividendrendement versus markt

Bora Pharmaceuticals Dividendrendement versus markt
Hoe verhoudt 6472 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (6472)1.6%
Markt onderkant 25% (TW)1.7%
Markt Top 25% (TW)4.4%
Gemiddelde industrie (Pharmaceuticals)2.2%
Analist prognose (6472) (tot 3 jaar)0%

Opmerkelijk dividend: Het dividend van 6472 ( 1.61% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de TW markt ( 1.69% ).

Hoog dividend: Het dividend 6472 ( 1.61% ) is laag vergeleken met de top 25% van dividendbetalers in de TW markt ( 4.32% ).


Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn redelijk lage payout ratio ( 38% ) worden de dividendbetalingen van 6472 ruimschoots gedekt door de winst.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: 6472 keert dividend uit, maar het bedrijf heeft geen vrije kasstromen.


Ontdek bedrijven met een sterk dividend